Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

->

Protect every IV line, every time

Every IV line connects to the patient's one bloodstream. Solventum IV site management solutions deliver clinically proven, uncompromising protection – because even one preventable bloodstream infection is one too many.

Help prevent bloodstream infections with solutions designed to prepare, secure and protect every IV access point from insertion to removal.

Img IV Care_web_antimicrobial-hero_1200x350.jpg
Overview Our solutions Product resources Evidence and guidance Support resources Contact us
On this page...
Overview
Our solutions
Product resources
Evidence and guidance
Support resources
Contact us

Stop bloodstream infections before they start

IV therapy is a critical and fundamental part of patient care. While infusion therapy is a common way to deliver fluids and other medications, it comes with risks.

In fact, catheter-associated bloodstream infections (CABSIs) can occur at the time of the initial insertion or anytime throughout the duration of intravenous access — creating the potential for longer hospital stays1-5, increased care costs2,4 and higher patient mortality.2

Icon showing a microbe, germ, used for infection prevention, BSI or CIP

Explore our range of solutions to help reduce VAD-related complications

From skin protection, catheter securement and antimicrobial protection, our solutions are designed to reduce both extraluminal and intraluminal risks.

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing is the only transparent dressing indicated and proven to reduce CRBSI and vascular catheter colonization that align with evidence-based guidelines and practice standards.

View product

View product

3M™ Curos™ Disinfecting Cap for Needleless Connectors, CFF1

3M™ Curos™ Disinfecting Cap for Needleless Connectors, CFF1

Designed to disinfect and protect ports in one minute, the Curos Disinfecting Cap for Needleless Connectors contains 70% isopropyl alcohol (IPA), helping to decrease the risk of central line-associated bloodstream infection (CLABSI)1 on I.V. needleless connectors.

View product

View product

3M™ Tegaderm™ Antimicrobial I.V. Advanced Securement Dressing 9132

3M™ Tegaderm™ Antimicrobial I.V. Advanced Securement Dressing 9132

The Tegaderm Antimicrobial I.V. Advanced Securement Dressing 9132 is a peripheral IV securement dressing with chlorhexidine gluconate (CHG) formulated into the dressing adhesive. Its integrated design combines antimicrobial protection with site visibility, catheter securement and consistent application for peripheral IVs.

View product

View product

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing

3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing

Tegaderm CHG Chlorhexidine Gluconate I.V. Port Dressing is an antimicrobial dressing designed for patients with implanted venous ports, including oncology and hematology patients.

View product

View product

3M™ PICC/CVC Securement Device + 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

3M™ PICC/CVC Securement Device + 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

PICC/ CVC Securement Device + Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing is an engineered stablization device (ESD) plus antimicrobial (CHG) dressing designed to provide immediate and continuous antimicrobial protection for up to 7 days. Using a sutureless securement device is recommended by the Joint Commision.

View product

View product

Collage VAS Catheters PICC, PIV, CVC, Port different formats CER 8 600x300

IV dressings selection guide

Discover our family of trusted IV dressings to help protect patients and reduce the risk of costly complications.

Download the guide

References:

  1. Maki D, Mermel L. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Bennett & Brachman’s Hospital Infections. 4th ed. Philadelphia: Lippincott-Raven; 1998:689-724.
  2. Signs, CDC Vital. "Making healthcare safer: Reducing bloodstream infections." Morbidity and Mortality Weekly Report 60, no. 8 (2011): 243-248.
  3. Blot, Stijn I., Pieter Depuydt, Lieven Annemans, Dominique Benoit, Eric Hoste, Jan J. De Waele, Johan Decruyenaere, Dirk Vogelaers, Francis Colardyn, and Koenraad H. Vandewoude. "Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections." Clinical Infectious Diseases 41, no. 11 (2005): 1591-1598.
  4. Zimlichman, Eyal, Daniel Henderson, Orly Tamir, Calvin Franz, Peter Song, Cyrus K. Yamin, Carol Keohane, Charles R. Denham, and David W. Bates. "Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system." JAMA internal medicine 173, no. 22 (2013): 2039-2046.
  5. Scheithauer, S., K. Lewalter, J. Schröder, A. Koch, H. Häfner, V. Krizanovic, K. Nowicki, R-D. Hilgers, and S. W. Lemmen. "Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing." Infection 42, no. 1 (2014): 155-159.